CDC Telebriefing on National Immunization Survey- Teen results and HPV vaccination coverage among adolescents – Transcript
Federal Information & News Dispatch, Inc. |
Press Briefing Transcript
CDC Telebriefing on
Audio recording [MP3, 6.2 MB]
OPERATOR: Excuse me, this is the conference coordinator. Please continue to hold. The conference will begin shortly. Please continue to hold while the others join. Thank you.
Welcome and thank you for standing by. At this time all participants are in a listen-only mode. During the question and answer session please press star 1 on your phone. Today's conference call is being recorded. If you have any objections, you may disconnect at this time. I would like to turn today's meeting to
A second report in today's MMWR provides an in-depth look at HPV vaccination coverage and updates information on the safety of this vaccine. I'm going to discuss three areas briefly; new data on vaccine coverage among teen boys and girls from the NIS- Teen, missed opportunities for HPV vaccination and why strong recommendations from clinicians are so important. The MMWR articles include data on vaccination rates from the
Among teens 13 to 17 years of age, the 2013 survey found very small increases in each of the three routine teen vaccinations. HPV vaccination coverage for girls increased 3.5 percentage points from 53.8 percent in 2012 to 57.3 percent in 2013. Coverage for meningococcal conjugate vaccine increased 3.8 percentage points from 74 percent in 2012 to 77.8 percent in 2013. Tdap coverage was already high at 84.6 percent in 2012, but it increased another 1.4 percentage points to 86.0 percent in 2013. It is a relief that we did not continue to have flat lining HPV coverage in 2013. You may recall there was absolutely no improvement from 2011 to 2012. The increase we did see in the 2013 results was quite small at the national level. We looked intensively to see if there were any more encouraging signs, and as I had said, we were disappointed with the overall findings.
However, I'd like to highlight five states that did have significant, impressive increases in HPV coverage between 2012 and 2013. These states are
In 2012 many other states are taking on these same kinds of activities so we'll need to see if that helps improve the national picture. The HPV vaccination report today describes missed opportunities for HPV vaccination. When a teen is in the doctor's office and receives another vaccine, but not HPV, that's a missed opportunity. Based on the survey we estimate that if every time an 11 or 12-year-old was getting another vaccine, HPV was given as well, HPV coverage by the 13th birthday would have been 91 percent instead of 47 percent. This data are for girls. Our system is clearly missing many opportunities to vaccinate against HPV-related cancers. We are urging clinicians to strongly recommend HPV vaccine the same way and the same day they recommended and administer meningococcal conjugate and Tdap vaccines.
The data show that a recommendation from a healthcare professional is strongly associated with teens getting vaccinated. One of the top five reasons parents listed for not getting the HPV vaccine for their son or daughter was that it hadn't been recommended to them by their teen's doctor or nurse. The parents that vaccinated their daughter against HPV, 74 percent had received a recommendation from a healthcare professional, while 52 percent of parents that didn't vaccinate their daughter recalled the vaccine being recommended to them. HPV vaccination of boys is still being seen as fairly new and it appears from the 2013 survey data that fewer clinicians were recommending it routinely. A clinician recommendation was very important in boys, too. Seventy-two percent of parents that vaccinated their son received a recommendation compared to only 26 percent of parents that didn't vaccinate their son.
Let me briefly mention the other vaccine data. Vaccination with Tdap and meningococcal conjugate vaccine continues to be strong with 86 percent of teens having gotten Tdap and 77.8 percent having gotten the first meningococcal conjugate vaccine dose. In
We encourage parents and caregivers to ask about vaccination every time they take their kids for a health care visit whether their children are babies and toddlers or tweens and teens. Recent outbreaks highlight the importance of adolescent immunization. Several areas are seeing increases in whooping cough this year and every single case of meningococcal meningitis is a medical emergency. Vaccines can't prevent all of those illnesses, but people who are vaccinated are much less likely to get these diseases. I know many parents are starting to think about their back-to-school chores. Stocking up on school supplies and scheduling sports physicals. This is a great time to make sure your teens have gotten all of the recommended vaccinations and all 11 or 12-year-olds, girls and boys, should be protected from meningitis, whooping cough and HPV-associated cancers.
The results we are reporting today are disappointing. There are about 14 million new HPV infections every year, most often acquired in people in their teens and 20s. HPV vaccine can prevent infections caused by vaccine-type strains. People who have persistent HPV infections can develop a variety of cancers and even in a setting of good national screening efforts. Every 20 minutes an American is diagnosed with an HPV-associated cancer. The HPV infections we don't prevent this year may be the first step in development of cancers for some of our nation's young people. Our continuing good results with Tdap and meningococcal vaccines show us that our system can reach high levels of adolescents with recommended vaccines, but the minimal progress with HPV vaccination reminds us there is a lot more we have to do. This year we don't have a big news story on teen vaccination results, but in this case no news is bad news for cancer prevention. I'd like to take questions, operator.
OPERATOR: Thank you. We'll begin the question and answer session. If you'd like to ask a question, please press star 1. Please unmute the phone and record your name clearly when prompted. To withdraw your request, press star 2, wait just a moment for our first question.
Our first question comes from
OPERATOR: Thank you. Our next question comes from
OPERATOR: Our next question comes from
OPERATOR: Our next question comes from
OPERATOR:Our next question comes from
DAN CHILDS:Thank you so much for taking my call. Just a quick question about the fact that we're looking at greater than or equal to one dose in this. We know that the HPV vaccine is a three-dose course, and we see the number for the three doses is still quite a bit smaller than those getting one dose. What are some of the challenges that-- that I guess, doctors and perhaps even parents face with regard to this and can this really be remedied by, I guess, asking or having the clinician talk about HPV at a single visit when, in fact, what we're talking about is three encounters with a health care professional?
There are a number of issues being looked at right now. There are other countries that have changed their recommendations to have a two-dose series, instead of a three-dose series particularly when the series is initiated early before age 13 or 14 and that's not early, that's actually on time, but essentially changing to have a two-dose for the younger kids and a three-dose if you're initiating at 15 or later. In
OPERATOR: Our next question comes from
BETH GREENFIELD:Okay.
So I think it's very important to say that we take seriously vaccine safety and do not consider it light to give vaccines to totally healthy people. There's no scientific causal relationship between the HPV vaccine and those long term events.There are continued review, and this is the kind of thing that we don't stop after a vaccine is in widespread use. We continue to look for rare signals, but the preponderance of evidence does not suggest any kind of serious problem from the HPV vaccine or other teen vaccines. What I do need to say is that teenagers sometimes faint after vaccination. We think it's really important for the teens, the parents and the clinicians to observe them for 15 minutes or so after vaccine is given because kids are just running off and sometimes pass out and there actually was even a death from someone who fainted shortly after getting one of these vaccines and was in a car accident. So we think it's important to not jump off the table and run off and go about your business, but to actually rest for 15 minutes. So that's the kind of thing that is more common in teenagers after any vaccine than in babies and toddlers, but thanks for that question.Operator, we have time for two more callers if there are any.
OPERATOR: Thank you. Our next question comes from
ALYSON WYCOFF:Thank you. Could you elaborate on the methods used by the five states that showed the best improvement in HPV vaccination rates and repeat those states, please?
Some of them worked with cancer coalitions to put this into the strategic plans or priorities that the cancer groups like Cervical Cancer-Free South Carolina were using and some had general health initiatives that they incorporated HPV into. They did different things, but I think one commonality is that they focused on how in their local area they could improve coverage. Right now, CDC is working with a number of other states and of course, we're working with the
OPERATOR:We're taking our last question with
BENJAMIN HAYNES:Thank you, Dr. Schuchat and thank you all for calling. A transcript will be available of the telebriefing this afternoon at www.cdc.gov/media, and if you have further questions you can call 404-639-3286 or email [email protected]. Thank you.
OPERATOR: Thank you. Thank you all for attending today's conference. You may now disconnect.
Copyright: | (c) 2011 Federal Information & News Dispatch, Inc. |
Wordcount: | 4416 |
Conspirator Sentenced to Prison for $1.5 Million in Mortgage Fraud Losses
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News